准确性,可接受性和应用:便免疫化学测试,以早期检测基于结肠镜的监测中的晚期新生病

Molla M Wassie1, Maddison Dix2, Geraldine Laven-Law2

  • 1Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, 5042, Australia. molla.wassie@flinders.edu.au.

概括

便免疫化学测试 (FIT) 被接受用于高风险个体的结直肠癌监测. 间隔FIT有助于更早地检测晚期瘤,可能会个性化结肠镜检查计划.